5HN-23335-45514
3 vaccinations
1 coded response
36 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 622 / IL
- Registered
- 2021-07-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-26
Registered in v-safe
-
2021-07-26
Dose 1 — Pfizer-BioNTech
- 2021-07-26
- 2021-07-27
-
2021-07-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-07-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-09
- 2021-08-16
-
2021-08-19
Dose 2 — Pfizer-BioNTech
-
2021-08-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling, Itching · HeadacheAdult check-in
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-09-02
- 2021-09-09
- 2021-09-16
- 2021-09-23
- 2021-09-30
- 2021-11-18
-
2022-01-29
Dose 3 — Pfizer-BioNTech
- 2022-01-29
-
2022-01-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2022-01-31
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Redness, Swelling, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Swelling, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Headache, Fatigue or tirednessAdult check-in
- 2022-02-05
- 2022-02-12
- 2022-02-19
-
2022-02-26
Survey response — day 28, dose 3MedDRA: Cough, Nasal congestion — Feeling: GoodFree text: Nasal congestion, dry coughMedDRA releases: 2024-11 · check-in free text available
- 2022-03-05
- 2022-03-12
- 2022-04-30
- 2022-07-30
- 2023-01-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-26 | Pfizer-BioNTech | No |
| 2 | 2021-08-19 | Pfizer-BioNTech | No |
| 3 | 2022-01-29 | Pfizer-BioNTech | No |
Free text
Release 11 — day 28, dose 3
Symptoms: Nasal congestion, dry cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release